MDS Pharma Services Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • MDS Pharma Services's estimated annual revenue is currently $158.4M per year.(i)
  • MDS Pharma Services's estimated revenue per employee is $201,000

Employee Data

  • MDS Pharma Services has 788 Employees.(i)
  • MDS Pharma Services grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$71M300-3%N/AN/A
#2
$2.6M13-38%N/AN/A
Add Company

MDS Pharma Services – The world's premier provider of innovative drug discovery and development solutions.\r\n\r\nWe offer a full spectrum of world-class discovery, preclinical and clinical resources and expertise, strategically located around the world, to meet the needs of the global pharmaceutical and biotech industries. Our broad range of services is designed to increase the speed, precision and productivity of your drug discovery and development activities. \r\n\r\nThrough 2009 and 2010, MDS Inc. divested the assets of MDS Pharma Services:\r\n- The former discovery and preclinical businesses (Pharmacology/DMPK and Drug Safety Assessment) have been acquired by Ricerca Biosciences LLC. \r\n- The former early stage clinical research operations (the Development & Regulatory Services consultancy and Early Stage Development business) have been acquired by Celerion Inc. \r\n- The former late stage clinical research operations (Global Clinical Development) have been acquired by INC Research.\r\n - The former clinical laboratory operations (Global Clinical Development) have been acquired by Clearstone Central Laboratories..

keywords:N/A

N/A

Total Funding

788

Number of Employees

$158.4M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MDS Pharma Services's People

NameTitleEmail/Phone
1
Method Develpment ScientistReveal Email/Phone
2
Director Client and Support ServicesReveal Email/Phone

MDS Pharma Services News

2022-04-17 - Bacterial Vaccines Market Size And Forecast | Serum Institute ...

... Emergent BioSolutions Inc., Pfizer Inc., Johnson & Johnson Services Merck & Co. Inc., GlaxoSmithKline plc., Sanofi S.A., Astellas Pharma...

2022-04-13 - Ketchum brings on Jen Fuhrman-Kestler and Angelena Abate ...

... has hired Jen Fuhrman-Kestler and Angelena Abate as EVPs and MDs. ... agency in January as EVP and managing director of health services.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$292.1M9152%N/A
#2
$294.9M10034%N/A
#3
$298.2M103710%N/A
#4
$243M108519%N/A
#5
$544.2M11965%N/A